Activity
Mon
Wed
Fri
Sun
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
What is this?
Less
More

Memberships

Peptide Researchers

6.6k members • Free

Castore: Built to Adapt

886 members • Free

27 contributions to Castore: Built to Adapt
NMN vs TND1128
@Anthony Castore what are your thoughts of TND1128 being superior over NMN as a NAD+ precursor? The studies I’ve read indicate that TND1128 is a superior MAM+ precursor for activating SIRTUINS, help self regulate redox, with anti antioxidant and anti-inflammatory properties. That being said, all the studies were conducted on mice and we know that there’s not a direct correlation.
0 likes • 4d
@Anthony Castore makes sense. Thank you!
BPC/TB4 and Cancer
I thought this might be right up your alley to discuss @Anthony Castore . I am seeing the topic pick up again about why you should avoid BPC/TB due to possible increase in cancer likelihood. I can't tell if this is all just fear mongering or not. There doesn't appear to be any evidence regarding this outside of referencing a mouse study that was done: ---------------------------------------------------------------------------------------------------------------------------------------------------------- "In most solid tumors studied in mice, including fibrosarcoma, melanoma, non-small cell lung cancer (NSCLC), colon cancer, and glioblastoma, TB4 overexpression promotes tumor growth, metastasis, and angiogenesis." ----------------------------------------------------------------------------------------------------------------------------------------------------------- One person is stating that since BPC up-regulates VEGF, this would be a pathway towards cancer development (below is what they posted). ----------------------------------------------------------------------------------------------------------------------------------------------- VEGF is historically a promoting factor in oncological aspects rather than causative, but this isn't the only concern. VEGF was originally named "vascular permeability factor" for a reason. It opens gaps between endothelial cells, letting plasma proteins and fluid leak into the interstitial space. Off-target stimulation means edema in tissues that don't need increased perfusion. The problem is that VEGF receptors sit on endothelial cells throughout the entire body, not just in the tissue you're trying to help. So if VEGF reaches non-target tissues, several things go wrong. It can produce off-target angiogenesis, meaning new blood vessel growth where you do not want it. That can produce abnormal, fragile, leaky vessels rather than healthy functional ones. VEGF also increases vascular permeability, so tissue can become swollen or edematous. PMID: 35969170, 20400620
0 likes • 4d
@Anthony Castore great explanation. Thanks Anthony!
ARA290
Has anyone here used ARA290?
2 likes • Nov '25
@Drew Wurst Thanks for the dosing info I tend to get results with lower doses but everybody’s receptors have different sensitivity. @Anthony Castore That being said, is ARA 290 a threshold or a saturation molecule?
4 likes • 29d
@Tom Modjeski My protocols vary specific to the athlete / individual I don’t believe “one size fits all” ARA 290 is one of my go to peptides or there’s a high degree of pain whether acute or chronic injury/condition. Starting dose of .05 to 1mg SQ daily, is effective for pain attenuation. I may increase dose to 1.5mg but it’s a threshold pepride so there’s a point of diminishing returns with bigger doses. For an acute condition, frequency 1x day for 7 and then reevaluation. For chronic, cycle 5 days on/3 days off. Timing can be a.m. or p.m. depending the individual. I haven’t found ARA 290 to disrupt sleep. I treat systemically. injecting at side of injury or pain is not necessary. If pain is still an issue with ARA 290, I will add TB 500 to the protocol rather than increasing dosage. These two peptides together are highly effective to further reduce pain as well as treat inflammation. When adding TB 500, I reduce the dose of ARA 290. These two peptides work just as well on Dogs and Horses as human humans
Most Fatigue Advice Fails Because It Confuses These Two Very Different Problems
Low energy is one of the most common complaints in medicine, coaching, and everyday life, yet it is one of the least precisely understood. People describe it as fatigue, burnout, brain fog, weakness, lack of motivation, or feeling “offline.” Athletes feel it when they cannot train. Patients feel it when they cannot work. High performers feel it when discipline no longer works. The problem is that “low energy” is not a diagnosis. It is a surface description of a system-level failure, and two people can experience nearly identical symptoms while the underlying biology is completely different. Treating them the same way helps one person and harms the other. To understand low energy correctly, you have to stop asking how to boost energy and start asking why energy is being limited in the first place. At the deepest level, there are two dominant failure modes. In one, the body cannot produce enough energy. In the other, the body is deliberately suppressing energy production. The first is mitochondrial damage, a capacity problem. The second is inflammatory inhibition, a regulatory decision. One is a broken engine. The other is a functioning engine with the brakes applied. Subjectively they feel similar. Biologically they are opposites. Everything that follows depends on recognizing which one you are dealing with. A simple model helps. Imagine the body as a car. The mitochondria are the engine. They take fuel and oxygen and convert them into usable energy in the form of ATP. Inflammation acts like the central control computer, deciding how much power the engine is allowed to produce. If the engine is damaged, pressing the accelerator does little. If the computer is limiting output, the engine could perform, but is being intentionally restrained. In both cases the car goes slow. Only one responds to pushing harder. Mitochondria exist inside nearly every cell and are responsible for producing ATP, the molecule that powers muscle contraction, nerve signaling, hormone synthesis, immune regulation, tissue repair, and cognition. Without adequate ATP, nothing in the body functions well. Energy production depends on intact mitochondrial membranes, functioning enzymes, proper redox balance, sufficient oxygen delivery, and a steady supply of micronutrients. When any part of this system is damaged, the maximum amount of energy the body can generate drops. This is not a motivational issue. It is a hard ceiling.
2 likes • Feb 8
@Anthony Castore Great insight. Thank you! For people fall somewhere in between, with both constraints present, which dysfunction would you prioritize and how would you proceed with treatment and rebuiding?
Jetlag
What protocol do you follow to minimize jet lag, avoid drops in HRV, and improve sleep after traveling to a different time zone? @Anthony Castore
1 like • Jan 22
@Anthony Castore great information as always, thank you Anthony! When I fly to Europe from the states, typically a redeye landing early morning, a small dose of melatonin helps me manage the jet lag. I run into difficulty resetting my circadian clock is there for an extended time. My schedule is physically intense and dinner is dictated by the European schedule which late night dining. Would you still recommend the use of ketones for adaption!
1-10 of 27
Beverly Haffeman
3
13points to level up
@beverly-haffeman-8045
Regenerative therapies specializing in cold laser, PEMF, peptides and homeopathics for athletes including Equine and K9 .

Active 3d ago
Joined Aug 3, 2025
Powered by